1810031K17Rik Activators encompass a diverse array of chemical compounds that serve to indirectly enhance the functional activity of 1810031K17Rik through modulation of specific signaling pathways. For example, Forskolin and Isoproterenol work to augment intracellular cAMP levels, which activates PKA - a kinase that can phosphorylate substrates involved in the pathways that 1810031K17Rik is a part of, thus enhancing its activity. Similar in their indirect effects, Epigallocatechin gallate and Genistein both act as kinase inhibitors, with the potential to relieve 1810031K17Rik from negative regulatory influences and promote its functional role in the cell. PKC activators like Phorbol 12-myristate 13-acetate, and calcium ionophores such as Ionomycin and A23187, further contribute to the enhancement of 1810031K17Rik by modulating signaling pathways related to phosphorylation and calcium-dependent processes, respectively.
Sphingosine-1-phosphate distinctly enhances 1810031K17Rik activity through its receptors, which are involved in various cellular signaling cascades. 1810031K17Rik Activators encompass a diverse array of chemical compounds that serve to indirectly enhance the functional activity of 1810031K17Rik through modulation of specific signaling pathways. For example, Forskolin and Isoproterenol work to augment intracellular cAMP levels, which activates PKA - a kinase that can phosphorylate substrates involved in the pathways that 1810031K17Rik is a part of, thus enhancing its activity. Similar in their indirect effects, Epigallocatechin gallate and Genistein both act as kinase inhibitors, with the potential to relieve 1810031K17Rik from negative regulatory influences and promote its functional role in the cell. PKC activators like Phorbol 12-myristate 13-acetate, and calcium ionophores such as Ionomycin and A23187, further contribute to the enhancement of 1810031K17Rik by modulating signaling pathways related to phosphorylation and calcium-dependent processes, respectively.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
EGCG is a kinase inhibitor known to affect multiple signaling pathways. It could enhance 1810031K17Rik activity by inhibiting kinases that negatively regulate pathways where 1810031K17Rik has a role, thus reducing inhibitory signals and allowing for increased activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC), which in turn can modulate signaling pathways that involve 1810031K17Rik, potentially enhancing its activity through phosphorylation events. | ||||||
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $94.00 $259.00 | 2 | |
Ionomycin is a calcium ionophore that raises intracellular calcium levels, thereby activating calcium-dependent signaling pathways that could indirectly increase the activity of 1810031K17Rik through downstream effects. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 is a PI3K inhibitor that can increase the activity of 1810031K17Rik by reducing PI3K/Akt signaling, potentially de-repressing pathways in which 1810031K17Rik is a participant. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
A23187 is a calcium ionophore that increases intracellular Ca2+ concentration, potentially enhancing the activity of 1810031K17Rik through the activation of calcium-dependent signaling pathways. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $162.00 $316.00 $559.00 $889.00 $1693.00 | 7 | |
S1P is a bioactive lipid that activates sphingosine-1-phosphate receptors and may indirectly enhance the activity of 1810031K17Rik by modulating cellular signaling pathways, including those related to cell survival and proliferation in which 1810031K17Rik might be involved. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
Staurosporine is a broad-spectrum protein kinase inhibitor that could selectively enhance the activity of 1810031K17Rik by inhibiting kinases that negatively regulate signaling pathways involving 1810031K17Rik. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
SB203580 is a specific inhibitor of p38 MAP kinase that might enhance the activity of 1810031K17Rik by modulating the cellular stress response pathways and shifting the balance towards pathways that activate 1810031K17Rik. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
Genistein is a tyrosine kinase inhibitor that could enhance the activity of 1810031K17Rik by inhibiting competitive signaling pathways and allowing for the activation of pathways where 1810031K17Rik is implicated. | ||||||